Overview
Aki Ishikawa practices in Sapporo, Japan. Ishikawa is rated as an Advanced expert by MediFind in the treatment of Proximal Symphalangism. Their top areas of expertise are Fetal Parvovirus Syndrome, Proximal Symphalangism, Multiple Synostoses Syndrome 1, and Metachondromatosis.
Their clinical research consists of co-authoring 31 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Proximal Symphalangism.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Fetal Parvovirus SyndromeIshikawa isAdvanced. Learn about Fetal Parvovirus Syndrome.
- MetachondromatosisIshikawa isAdvanced. Learn about Metachondromatosis.
- Multiple Synostoses Syndrome 1
- Parvovirus Antenatal Infection
- Proximal SymphalangismIshikawa isAdvanced. Learn about Proximal Symphalangism.
- Experienced
- Acromicric DysplasiaIshikawa isExperienced. Learn about Acromicric Dysplasia.
- Aplasia Cutis CongenitaIshikawa isExperienced. Learn about Aplasia Cutis Congenita.
- Arthrogryposis Multiplex CongenitaIshikawa isExperienced. Learn about Arthrogryposis Multiplex Congenita.
- BrachydactylyIshikawa isExperienced. Learn about Brachydactyly.
- Cafe-Au-Lait SpotsIshikawa isExperienced. Learn about Cafe-Au-Lait Spots.
- Cardiofaciocutaneous SyndromeIshikawa isExperienced. Learn about Cardiofaciocutaneous Syndrome.